Submitted by Anonymous (not verified) on 8 October 2026 - 12:16
Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tepmetko, tepotinib, Date of authorisation: 16/02/2022, Revision: 6, Status: Authorised